 Connection
Christina Chambers to Teratogens
This is a "connection" page, showing publications Christina Chambers has written about Teratogens.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.916 |
|
|
|
-
Chambers C, Johnson DL, Kiernan E. Approach to evaluating pregnancy safety of anti-rheumatic medications in the OTIS MotherToBaby pregnancy studies: what have we learned? Rheumatology (Oxford). 2018 07 01; 57(suppl_5):v34-v39.
Score: 0.556
-
Mody SK, Farala JP, Wu J, Felix R, Chambers C. Using the electronic medical record to assess contraception usage among women taking category D or X medications. Birth Defects Res A Clin Mol Teratol. 2015 Oct; 103(10):887-91.
Score: 0.457
-
Mody SK, Wu J, Ornelas M, Kernahan C, Salas E, Kao K, Felix R, Chambers C. Using the electronic medical record to refer women taking category D or X medications for teratogen and contraceptive counseling. Birth Defects Res A Clin Mol Teratol. 2015 Jul; 103(7):644-7.
Score: 0.451
-
Ewig CLY, Wang Y, Smolinski NE, Toyserkani GA, LaCivita C, Lackey L, Eggers S, Sahin L, Abu-Rustum RS, Bateman BT, Berard A, Chambers CD, Choby B, Conover EA, Greene MF, Hernández-Díaz S, Jamieson DJ, Obican SG, Polifka JE, Roussos-Ross K, Sheffield JS, Lavigne SV, Zimmermann EM, Laffan SB, DeLise AM, Gilsenan AW, Hammad TA, Hampp C, Hardy JR, Knox CA, Shields K, Smith MY, Sobel RE, Tassinari MS, Maro JC, Rasmussen SA, Winterstein AG. Teratogenic Risk Impact Mitigation (TRIM): Development of Explicit Criteria to Facilitate Decisions Regarding Teratogenic Risk Mitigation Strategies. Drug Saf. 2025 Dec; 48(12):1387-1397.
Score: 0.227
-
Lyons Jones K, Johnson DL, Chambers CD. Monitoring leflunomide (Arava) as a new potential teratogen. Teratology. 2002 May; 65(5):200-2.
Score: 0.181
-
Goldberg BB, Alvarado S, Chavez C, Chen BH, Dick LM, Felix RJ, Kao KK, Chambers CD. Prevalence of periconceptional folic acid use and perceived barriers to the postgestation continuance of supplemental folic acid: survey results from a Teratogen Information Service. Birth Defects Res A Clin Mol Teratol. 2006 Mar; 76(3):193-9.
Score: 0.015
-
Robertson J, Polifka JE, Avner M, Chambers C, Delevan G, Koren G, Lavigne SV, Martinez LP, Miller RK, Carey JC. A survey of pregnant women using isotretinoin. Birth Defects Res A Clin Mol Teratol. 2005 Nov; 73(11):881-7.
Score: 0.014
-
Felix RJ, Jones KL, Johnson KA, McCloskey CA, Chambers CD. Postmarketing surveillance for drug safety in pregnancy: the Organization of Teratology Information Services project. Birth Defects Res A Clin Mol Teratol. 2004 Dec; 70(12):944-7.
Score: 0.014
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|